AVGO
69
20
XRX
52
-3
TGT
50
-2
VRTX
53
-2
WMB
60
4
FTI
82
4
TROW
34
-5
ALL
61
-2
COST
56
3
TRV
64
2
HOG
50
6
FOXA
48
7
CAG
46
10
APA
25
-3
MAS
67
-3
EXC
53
6
ADP
69
-3
INTC
43
6
KEY
51
-3
NTRS
49
-5
AVGO
69
20
XRX
52
-3
TGT
50
-2
VRTX
53
-2
WMB
60
4
FTI
82
4
TROW
34
-5
ALL
61
-2
COST
56
3
TRV
64
2
HOG
50
6
FOXA
48
7
CAG
46
10
APA
25
-3
MAS
67
-3
EXC
53
6
ADP
69
-3
INTC
43
6
KEY
51
-3
NTRS
49
-5
Financhill
Back

abrdn Life Sciences Investors Stock Predictions

32,481% Growth? Meet Mode Mobile's "EarnPhone"

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
43

HQL
abrdn Life Sciences Investors

Last Price:
15.52
Seasonality Move:
-2.57%

7 Day Trial

ALL ACCESS PASS

$ 7

"EarnPhone": The Investment Hidden in Plain Sight

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.

abrdn Life Sciences Investors Stock Forecast

  • Over the next 52 weeks, abrdn Life Sciences Investors has on average historically risen by 6% based on the past 26 years of stock performance.
  • abrdn Life Sciences Investors has risen higher in 14 of those 26 years over the subsequent 52-week period, corresponding to a historical accuracy of 53.85%
  • Is abrdn Life Sciences Investors Stock Undervalued?
    The current abrdn Life Sciences Investors [HQL] share price is $15.55. The Score for HQL is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
  • HQL is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.

Will abrdn Life Sciences Investors Stock Go Up Next Year?

  • Over the next 52 weeks, abrdn Life Sciences Investors has on average historically risen by 6% based on the past 26 years of stock performance.

abrdn Life Sciences Investors Stock Rating

Sell
43
abrdn Life Sciences Investors (HQL) is a Sell

Is abrdn Life Sciences Investors overpriced?

  • abrdn Life Sciences Investors has risen higher in 14 of those 26 years over the subsequent 52-week period, corresponding to a historical accuracy of 53.85%

abrdn Life Sciences Investors Stock Price History

Is HQL stock going to rise?

  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and HQL is experiencing slight selling pressure.

Stock Information

Stock Info

Exchange:
NYSE
Country:
United States
Industry:
Sector:
Type:
stock
Website:
abrdnhql.com

52-Week Data

52-Week High:
15.90
52-Week Low:
11.34

Prediction Charts

Market Cap:
0
Price in USD:
15.55
Volume:
79.73K
Beta:
0.95

Technical Analysis

SMA50:
15.24
SMA100:
14.55
SMA200:
14.04
52-Wk Change:
23.51%

Stock Predictions

  • Is abrdn Life Sciences Investors stock public?
    Yes, abrdn Life Sciences Investors is a publicly traded company.
  • What is the abrdn Life Sciences Investors stock quote today?
    The abrdn Life Sciences Investors stock price is 15.55 USD today.
  • How to buy abrdn Life Sciences Investors stock online?
    You can buy abrdn Life Sciences Investors shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Sep-3 15.10 14.91 15.11 14.88
Sep-4 14.88 14.85 15.04 14.80
Sep-5 14.85 14.77 14.93 14.73
Sep-6 14.77 14.69 14.94 14.69
Sep-9 14.79 14.90 15.01 14.79
Sep-10 14.94 15.00 15.09 14.88
Sep-11 15.00 15.00 15.05 14.95
Sep-12 15.02 15.05 15.15 15.01
Sep-13 15.15 15.28 15.30 15.15
Sep-16 15.34 15.54 15.54 15.24
Sep-17 15.62 15.45 15.63 15.40
Sep-18 15.52 15.36 15.55 15.24
Sep-19 15.45 15.54 15.63 15.45
Sep-20 15.65 15.55 15.68 15.49

abrdn Life Sciences Investors Earnings

Data Unavailable

abrdn Life Sciences Investors Forecast Revenue Growth

Data Unavailable

* abrdn Life Sciences Investors stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.